For Immediate Release
Chicago, IL – July 7, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: ConocoPhillips
COP
, SAP SE
SAP
, CSX Corp.
CSX
, Alnylam Pharmaceuticals, Inc.
ALNY
and NVR, Inc.
NVR
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for ConocoPhillips, SAP and CSX
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including ConocoPhillips, SAP SE and CSX Corp. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can
see all of today’s research reports here >>>
ConocoPhillips
shares have gained +43.4% over the past year against the Zacks Oil and Gas – Integrated U.S. industry’s gain of +45.9%. The Zacks analyst believes that significant opportunities are there for the firm in the Bakken Shale, where it owns about 750 undrilled locations that could provide access to huge reserves.
Notably, the company has revised its expected 2022 return of capital to shareholders upward to $10 billion, reflecting an increase from the prior-mentioned $8 billion. Also, the company’s balance sheet is significantly less leveraged than the industry it belongs to.
However, ConocoPhillips is highly exposed to oil price fluctuations, which is make things challenging for the company. Also, it has been generating lower dividend yield than the composite stocks belonging to the energy sector over the past few years.
(You can
read the full research report on ConocoPhillips here >>>
)
SAP
shares have declined -39.6% over the past year against the Zacks Computer – Software industry’s decline of -15.4%. The Zacks analyst believes that suspension of Russian operations amid the ongoing Ukraine war is expected to affect both the company’s revenues and non-IFRS operating profit in the near term.
Weak uptake of software licenses and support offerings remains a headwind. Stiff competition and increasing costs to enhance cloud-based offerings is likely to exert pressure on the company’s profitability as well.
However, SAP’s performance is gaining from strength in its cloud business, especially the new Rise with SAP solution. Momentum in SAP’s Business Process Intelligence platform, particularly the S/4HANA solutions along with steady traction witnessed in SuccessFactors Employee Central, Ariba and Fieldglass, Qualtrics and other cloud-based offerings is noteworthy.
(You can
read the full research report on SAP here >>>
)
Shares of
CSX
have declined -13.6% over the past year against the Zacks Transportation – Rail industry’s decline of -9.4%. The Zacks analyst believes that supply-chain disturbances are hurting the company’s operations. Weakness in the merchandise segment due to lower automotive volumes is concerning. High costs, primarily due to escalating fuel expenses, pose a threat to CSX’s bottom line. CSX’s high capital expenditures are also worrisome.
However, CSX is benefiting from higher export coal volumes, domestic intermodal shipments and favorable pricing. With the demand scenario expected to remain strong, despite the current market bloodbath, management anticipates double-digit growth in operating income and revenues for 2022 from the respective year-ago reported figures.
(You can
read the full research report on CSX here >>>
)
Other noteworthy reports we are featuring today include Alnylam Pharmaceuticals, Inc., and NVR, Inc.
Why Haven’t You Looked at Zacks’ Top Stocks?
Our 5 best-performing strategies have blown away the S&P’s impressive +28.8% gain in 2021. Amazingly, they soared
+40.3%, +48.2%, +67.6%, +94.4%,
and
+95.3%
. Today you can access their live picks without cost or obligation.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss
.
This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit
https://www.zacks.com/performance
for information about the performance numbers displayed in this press release.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
